Health care studies by Dr. Oestreich + Partner GmbH

Health care studies

The company Dr. Oestreich Partner GmbH provides a comprehensive full service in the area of health care studies. On behalf of our customers, we manage entire projects in the fields of health economics, pharmacoeconomics, medicinal products and patient care. This includes the implementation of quality assurance measures and the identification and application of appropriate statistical methods (cost-benefit analysis, cost-effectiveness analysis, discounting, etc.) in all areas of basic and patient-oriented research. Since 1991, our full-service research institute has successfully carried out health care studies including studies on the economics of health care and long-term clinical projects. On behalf of our customers we carry out project planning, project management, financial management and budgetary control, statistical analysis and reporting for all types of health care studies. We also conduct projects on patient satisfaction, quality of life or efficacy of treatment, and evidence-based health care strategies.

Click here for an overview of health care studies:

http://www.oandp-cro.com/software-solutions/acceleration/

Health care studies: Individual proprietary software solutions at Dr. Oestreich + Partner GmbH

Customised and multi-lingual electronic case report forms (eCRF), which also allow the integration of external data (laboratory results, results of diagnostic imaging procedures, ECG, etc.) can be developed using our web-based databases PMSBOX and OPVERDI. We will design and create the electronic CRFs for you or, if preferred, you can design and prepare them yourself under our guidance. The databases are available to all authorised project staff throughout the entire project and enable the viewing and processing of data and test results online.

In addition, we provide telemedicine devices by means of which inpatients and outpatients can be continuously or intermittently monitored. Furthermore, the databases facilitate the measurement of data with respect to patient compliance, the efficacy and safety of treatment in addition to the product’s added value compared to the existing standard treatment. The results of these health care studies are transmitted to a server where they are automatically analysed and flagged, and then interpreted by qualified staff. In this way, effective patient monitoring together with the accurate recording and analysis of data from health care studies is realised without the need for face to face medical appointments. However, if necessary, the patient may be contacted at any time.

Click here for an overview of our proprietary software solutions for health care studies:

http://www.oandp-cro.com/software-solutions/acceleration/


EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Pharmacovigilance
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
ICH GCP E6
GCP Guidelines
GCP Compliance
BfArM GCP
Clinical Research Organisation
Contract Research Organisation
PSUR
PSURs
Pharmacoeconomics, Health
Pharmacoeconomic studies
Pharmacoeconomics
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection